[Clinical and pathological characteristics of Helicobacter pylori-associated chronic gastritis]

Z H Yan1, B Q Jia

  • 1Department of Gastroenterology, First Teaching Hospital, Beijing Medical University.

Zhonghua Nei Ke Za Zhi
|October 1, 1993
PubMed

Insights

Helicobacter pylori (Hp) infection significantly worsens chronic gastritis severity and pathology, including atrophy and intestinal metaplasia. However, clinical symptoms and gastric acid secretion remain similar between Hp-positive and Hp-negative patients.

Area of Science:

  • Gastroenterology
  • Pathology
  • Microbiology

Background:

  • Helicobacter pylori (Hp) is a common pathogen linked to various gastrointestinal diseases.
  • Chronic gastritis is a prevalent condition with diverse etiologies.
  • Understanding Hp's specific pathological impact is crucial for diagnosis and management.

Purpose of the Study:

  • To delineate the clinical and pathological features of Helicobacter pylori-associated gastritis.
  • To compare Hp-positive and Hp-negative chronic gastritis patients.

Main Methods:

  • A comparative study involving 173 patients with chronic gastritis.
  • Categorization into Hp-positive (99 patients) and Hp-negative (74 patients) groups.
  • Assessment of clinical symptoms, gastric acid secretion, gastrin levels, gastritis grades, and histological changes (atrophy, intestinal metaplasia).

Main Results:

  • No significant differences in clinical symptoms, gastric acid secretion, or basal gastrin levels between Hp-positive and Hp-negative groups.
  • Markedly higher grades of chronic and active gastritis in Hp-positive patients.
  • Hp infection confirmed in 91.2% of patients with active gastritis.
  • Increased Hp density correlated with higher gastritis grades, particularly severe active gastritis.
  • Significantly higher prevalence of glandular atrophy and intestinal metaplasia in the antral mucosa of Hp-positive patients.
  • No significant difference in overall duodenogastric reflux rates, but a trend towards lower moderate-to-severe reflux in Hp-positive patients.

Conclusions:

  • Helicobacter pylori infection is strongly associated with increased severity of chronic gastritis, active gastritis, glandular atrophy, and intestinal metaplasia.
  • Clinical presentation and gastric acid secretion do not reliably differentiate Hp-positive from Hp-negative gastritis.
  • Histopathological assessment is key for identifying Hp-associated changes.

Related Concept Videos

Pathophysiology of Peptic Ulcer Disease: Injurious Factors01:22

Pathophysiology of Peptic Ulcer Disease: Injurious Factors

Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds to M3...
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Peptic Ulcer01:27

Peptic Ulcer

Peptic ulcers are erosive lesions of the gastric or duodenal lining, most commonly caused by Helicobacter pylori infection. This Gram-negative, helical bacterium has adapted to survive the stomach’s acidic environment by producing urease, which converts urea into ammonia and carbon dioxide. The ammonia neutralizes gastric acid in the bacterium’s immediate environment, allowing colonization of the gastric mucosa. H. pylori attaches to mucus-secreting epithelial cells, penetrates the mucus...
Gastritis II: Pathophysiology01:26

Gastritis II: Pathophysiology

The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...